Millipore Sigma Vibrant Logo

344216 Formyl Peptide Receptor-Like 1 Agonist, WKYMVm - Calbiochem

The Formyl Peptide Receptor-Like 1 Agonist, WKYMVm controls the biological activity of Formyl Peptide Receptor-Like 1. This small molecule/inhibitor is primarily used for Activators/Inducers applications.

Ficha de datos de seguridad (MSDS o SDS), certificado de análisis y de calidad (CoA y CoQ), expedientes, folletos y otros documentos disponibles.

Sinónimos: H₂N-WKYMV-D-M-CONH₂, FPRL1 Agonist, WKYMVm

View Products on Sigmaaldrich.com
344216
Ver precios y disponibilidad

Descripción

Replacement Information

Precios y disponibilidad

Número de referencia DisponiblidadEmbalaje Cant./Env. Precio Cantidad
344216-5MG
Comprobando disponibilidad...
—
Disponibilidad a confirmar Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

      		 Ampolla de plást. 5 mg
      Recuperando precio...
      No pudo obtenerse el precio
      La cantidad mínima tiene que ser múltiplo de
      Maximum Quantity is
      Al finalizar el pedido Más información
      Ahorró ()
       
      —
      Solicitar precio
      		 —
      Description
      OverviewA potent chemoattractant that enhances leukocyte activity via activation of Formyl Peptide Receptor-Like 1 (FPRL1). Shown to activate phospholipase C-mediated inositol phosphate formation in human U266 myeloma cells (EC50 = 510 pM). Also shown to stimulate inositol phosphate formation in U937 and HL60 cells, but has no effect on a variety of other cell lines (e.g. NIH3T3, PC12, Daudi, Sp2, Jurkat, H9, Molt-4, SupT-1, K562, and RBL-2H3). Stimulates phagocyte chemotaxis and [Ca2+] flux, and is more effective than fMLP (Cat. No. 05-22-2500) in generating superoxide in human neutrophils. Radioiodinatable at the tyrosine residue.
      Catalogue Number344216
      Brand Family Calbiochem®
      SynonymsH₂N-WKYMV-D-M-CONH₂, FPRL1 Agonist, WKYMVm
      References
      ReferencesBae, Y.S., et al. 2004. J. Immunol. 173, 607.
      Bae, Y.S., et al. 2003. Mol. Pharmacol. 64, 841.
      Le, Y., et al. 1999. J. Immunol. 163, 6777.
      Seo, J.K., et al. 1997. J. Immunol. 158, 1895.
      Baek, S.H., et al. 1996. J. Biol. Chem. 271, 8170.
      Product Information
      ATP CompetitiveN
      FormLyophilized
      FormulationSupplied as a trifluoroacetate salt.
      Hill FormulaC₄₁H₆₁N₉O₇S₂
      Chemical formulaC₄₁H₆₁N₉O₇S₂
      Hygroscopic Hygroscopic
      ReversibleN
      Quality LevelMQ100
      Applications
      Biological Information
      Primary TargetFormyl Peptide Receptor-Like 1
      Primary Target IC<sub>50</sub>EC50 = 510 pM in activating phospholipase C-mediated inositol phosphate formation in human U266 myeloma cells
      Purity≥95% by HPLC
      Physicochemical Information
      Cell permeableN
      Peptide SequenceH-Trp-Lys-Tyr-Met-Val-D-Met-CONH₂
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped with Blue Ice or with Dry Ice
      Toxicity Standard Handling
      Storage -20°C
      Protect from Light Protect from light
      Hygroscopic Hygroscopic
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Número de referencia GTIN
      344216-5MG 04055977215328

      Documentation

      Formyl Peptide Receptor-Like 1 Agonist, WKYMVm - Calbiochem Ficha datos de seguridad (MSDS)

      Título

      Ficha técnica de seguridad del material (MSDS) 

      Formyl Peptide Receptor-Like 1 Agonist, WKYMVm - Calbiochem Certificados de análisis

      CargoNúmero de lote
      344216

      Referencias bibliográficas

      Visión general referencias
      Bae, Y.S., et al. 2004. J. Immunol. 173, 607.
      Bae, Y.S., et al. 2003. Mol. Pharmacol. 64, 841.
      Le, Y., et al. 1999. J. Immunol. 163, 6777.
      Seo, J.K., et al. 1997. J. Immunol. 158, 1895.
      Baek, S.H., et al. 1996. J. Biol. Chem. 271, 8170.
      Ficha técnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision26-June-2008 RFH
      SynonymsH₂N-WKYMV-D-M-CONH₂, FPRL1 Agonist, WKYMVm
      DescriptionA potent chemoattractant that enhances leukocyte activity via activation of Formyl Peptide Receptor-Like 1 (FPRL1). More poteut than fmlp at inducing neutrophil chemotaxis, neutrophil complement receptor 3. Shown to activate phospholipase C-mediated inositol phosphate formation in human U266 myeloma cells (EC50 = 510 pM) and in U937 and HL60 cells. Has no effect inositide phosphate synthecs in a variety of other cell lines (e.g. NIH3T3, PC12, Daudi, Sp2, Jurkat, H9, Molt-4, SupT-1, K562, and RBL-2H3). Radioiodinatable at the tyrosine residue.
      FormLyophilized
      FormulationSupplied as a trifluoroacetate salt.
      Intert gas (Yes/No) Packaged under inert gas
      Chemical formulaC₄₁H₆₁N₉O₇S₂
      Peptide SequenceH-Trp-Lys-Tyr-Met-Val-D-Met-CONH₂
      Purity≥95% by HPLC
      SolubilityDMSO (10 mg/ml)
      Storage Protect from light
      -20°C
      Hygroscopic
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesBae, Y.S., et al. 2004. J. Immunol. 173, 607.
      Bae, Y.S., et al. 2003. Mol. Pharmacol. 64, 841.
      Le, Y., et al. 1999. J. Immunol. 163, 6777.
      Seo, J.K., et al. 1997. J. Immunol. 158, 1895.
      Baek, S.H., et al. 1996. J. Biol. Chem. 271, 8170.